Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
HighCape Capital, L.P. Insider Profile
4 Followers
HighCape Capital, L.P., Director, Ten Percent Owner at Aziyo Biologics, holds 9.10M shares in Aziyo Biologics (Ticker: ELUT). Most recently, HighCape Capital, L.P. Bought $2,101,577 shares of Aziyo Biologics on Aug 01, 2024 for an estimated value of 2.98M.
HighCape Capital, L.P. Aziyo Biologics (ELUT)Director, Ten Percent Owner
Aziyo Biologics (ELUT)
Director, Ten Percent Owner
Ranked #84,956 out of 98,187 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-34.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of HighCape Capital, L.P.'s holdings
Insider Roles
Director, Ten Percent Owner
Roles that HighCape Capital, L.P. holds in companies
Most Profitable Insider Trade
The most profitable trade made by HighCape Capital, L.P.
HighCape Capital, L.P.'s Trading History
List of latest transactions for each holding click on a transaction to see HighCape Capital, L.P.'s performance on stock
You May Also Like
HighCape Capital, L.P. insider profile FAQ
What is the percentage of profitable transactions made by HighCape Capital, L.P.?
The percentage of profitable transactions made by HighCape Capital, L.P. is 0%.
What is the average return per transaction made by HighCape Capital, L.P.?
The average return per transaction made by HighCape Capital, L.P. is -34.70%.
What stocks does HighCape Capital, L.P. hold?
HighCape Capital, L.P. holds: ELUT stocks.
What was HighCape Capital, L.P.’s latest transaction?
HighCape Capital, L.P. latest transaction was an Informative Buy of $2.98M.
What was HighCape Capital, L.P.'s most profitable transaction?
HighCape Capital, L.P.’s most profitable transaction was an Informative Buy of ELUT stock on August 1, 2024. The return on the trade was -12.50%.
What is HighCape Capital, L.P.'s role in Aziyo Biologics?
HighCape Capital, L.P.'s role in Aziyo Biologics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.